Intrauterine device placement at 3 versus 6 weeks postpartum: a randomized trial

Area of Science:

• Reproductive Health
• Contraception
• Postpartum Care

Background:

• Postpartum contraception is crucial for preventing unintended pregnancies.
• Intrauterine devices (IUDs) are highly effective reversible contraceptives.
• Timing of postpartum IUD placement can influence uptake and continuation.

Purpose of the Study:

• To compare the effectiveness of early (3-week) versus standard (6-week) postpartum intrauterine device (IUD) placement on IUD use at 3 months.
• To assess the feasibility, safety, and patient satisfaction of early postpartum IUD insertion.

Main Methods:

• A prospective randomized controlled trial involving postpartum women desiring intrauterine contraception.
• Participants were randomized to IUD placement at 3 weeks or 6 weeks postpartum.
• Transvaginal ultrasonography confirmed placement; pain and satisfaction were measured using visual analog scales.

Main Results:

• IUD use at 3 months postpartum did not differ significantly between the early (73.0%) and standard (75.3%) groups.
• No significant differences in pain or satisfaction were observed based on the timing of IUD insertion.
• Women in the standard group were more likely to have resumed intercourse before their IUD appointment.

Conclusions:

• Offering intrauterine device (IUD) placement at 3 weeks postpartum does not increase postpartum IUD use at 3 months compared to 6-week placement.
• Early postpartum IUD insertion is feasible, acceptable, and does not increase pain.
• Further research is needed to evaluate the risks and benefits of very early postpartum IUD placement.